tradingkey.logo
tradingkey.logo

Bio Rad Laboratories Inc

BIO
300.930USD
+1.070+0.36%
終値 12/19, 16:00ET15分遅れの株価
8.12B時価総額
損失額直近12ヶ月PER

Bio Rad Laboratories Inc

300.930
+1.070+0.36%

詳細情報 Bio Rad Laboratories Inc 企業名

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.

Bio Rad Laboratories Incの企業情報

企業コードBIO
会社名Bio Rad Laboratories Inc
上場日Mar 17, 1980
最高経営責任者「CEO」Schwartz (Norman D)
従業員数7700
証券種類Ordinary Share
決算期末Mar 17
本社所在地1000 Alfred Nobel Dr
都市HERCULES
証券取引所NASDAQ OMX NASDAQ Basic NYSE
United States of America
郵便番号94547
電話番号15107247000
ウェブサイトhttps://www.bio-rad.com/
企業コードBIO
上場日Mar 17, 1980
最高経営責任者「CEO」Schwartz (Norman D)

Bio Rad Laboratories Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.39M
+214.86%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
19.55K
+5.80%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
2.02K
+53.88%
Mr. Jonathan P. (Jon) Divincenzo
Mr. Jonathan P. (Jon) Divincenzo
President, Chief Operating Officer
President, Chief Operating Officer
919.00
--
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
896.00
+470.70%
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
808.00
+61.60%
Ms. Courtney C Enloe
Ms. Courtney C Enloe
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
612.00
+414.29%
Mr. Arnold A. Pinkston
Mr. Arnold A. Pinkston
Independent Director
Independent Director
308.00
--
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
308.00
--
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.39M
+214.86%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
19.55K
+5.80%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
2.02K
+53.88%
Mr. Jonathan P. (Jon) Divincenzo
Mr. Jonathan P. (Jon) Divincenzo
President, Chief Operating Officer
President, Chief Operating Officer
919.00
--
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
896.00
+470.70%
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
808.00
+61.60%

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
会社から関連データがまだ開示されていません。
地域別USD
会社名
収益
比率
United States
266.90M
40.96%
Europe
217.20M
33.33%
APAC
126.40M
19.40%
Other
41.10M
6.31%
事業別
地域別
会社から関連データがまだ開示されていません。

株主

更新時刻: Sun, Nov 30
更新時刻: Sun, Nov 30
株主統計
種類
株主統計
株主統計
比率
First Eagle Investment Management, L.L.C.
11.50%
The Vanguard Group, Inc.
8.17%
Alice N. Schwartz Revocable Trust
8.13%
BlackRock Institutional Trust Company, N.A.
6.77%
Schwartz (Norman D)
6.36%
他の
59.06%
株主統計
株主統計
比率
First Eagle Investment Management, L.L.C.
11.50%
The Vanguard Group, Inc.
8.17%
Alice N. Schwartz Revocable Trust
8.13%
BlackRock Institutional Trust Company, N.A.
6.77%
Schwartz (Norman D)
6.36%
他の
59.06%
種類
株主統計
比率
Investment Advisor/Hedge Fund
43.38%
Investment Advisor
40.44%
Individual Investor
8.25%
Corporation
8.13%
Hedge Fund
5.13%
Research Firm
1.16%
Bank and Trust
1.15%
Pension Fund
1.14%
Sovereign Wealth Fund
0.63%

機関投資家保有株

更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
1040
20.58M
101.60%
-3.97K
2025Q3
1095
20.58M
103.17%
+603.60K
2025Q2
1114
19.81M
108.02%
-855.27K
2025Q1
1146
19.96M
99.31%
-2.83M
2024Q4
1140
19.39M
101.48%
-657.49K
2024Q3
1121
20.03M
101.42%
-386.71K
2024Q2
1139
20.32M
91.46%
+1.29M
2024Q1
1154
19.07M
91.02%
-2.25M
2023Q4
1187
19.09M
89.28%
-259.69K
2023Q3
1170
19.31M
88.28%
-552.69K
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
First Eagle Investment Management, L.L.C.
2.52M
11.45%
+223.05K
+9.72%
Jun 30, 2025
The Vanguard Group, Inc.
1.84M
8.38%
-59.61K
-3.13%
Jun 30, 2025
Alice N. Schwartz Revocable Trust
1.78M
8.1%
--
--
May 01, 2025
BlackRock Institutional Trust Company, N.A.
1.54M
7.02%
-98.58K
-6.00%
Jun 30, 2025
Schwartz (Norman D)
447.98K
2.04%
+5.20K
+1.17%
Sep 06, 2025
Dimensional Fund Advisors, L.P.
999.57K
4.55%
+122.53K
+13.97%
Jun 30, 2025
Veritas Asset Management LLP
863.14K
3.92%
-49.98K
-5.47%
Jun 30, 2025
Ariel Investments, LLC
818.62K
3.72%
+93.96K
+12.97%
Jun 30, 2025
EARNEST Partners, LLC
605.89K
2.75%
+6.26K
+1.04%
Jun 30, 2025
State Street Investment Management (US)
584.37K
2.66%
-110.15K
-15.86%
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
Parnassus Value Select ETF
3.94%
First Trust Indxx Medical Devices ETF
2.15%
ROBO Global Healthcare Technology & Innovation ETF
1.61%
Schwab Ariel Opportunities ETF
1.6%
First Trust Health Care Alphadex Fund
1.49%
FPA Global Equity ETF
1.38%
First Eagle Global Equity ETF
1.21%
iShares Health Innovation Active ETF
1.17%
Pacer US Export Leaders ETF
1.03%
Harbor Health Care ETF
0.82%
詳細を見る
Parnassus Value Select ETF
比率3.94%
First Trust Indxx Medical Devices ETF
比率2.15%
ROBO Global Healthcare Technology & Innovation ETF
比率1.61%
Schwab Ariel Opportunities ETF
比率1.6%
First Trust Health Care Alphadex Fund
比率1.49%
FPA Global Equity ETF
比率1.38%
First Eagle Global Equity ETF
比率1.21%
iShares Health Innovation Active ETF
比率1.17%
Pacer US Export Leaders ETF
比率1.03%
Harbor Health Care ETF
比率0.82%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし

よくある質問

Bio Rad Laboratories Incの上位5名の株主は誰ですか?

Bio Rad Laboratories Incの上位5名の株主は以下のとおりです。
First Eagle Investment Management, L.L.C.は2.52M株を保有しており、これは全体の11.45%に相当します。
The Vanguard Group, Inc.は1.84M株を保有しており、これは全体の8.38%に相当します。
Alice N. Schwartz Revocable Trustは1.78M株を保有しており、これは全体の8.10%に相当します。
BlackRock Institutional Trust Company, N.A.は1.54M株を保有しており、これは全体の7.02%に相当します。
Schwartz (Norman D)は447.98K株を保有しており、これは全体の2.04%に相当します。

Bio Rad Laboratories Incの株主タイプ上位3種は何ですか?

Bio Rad Laboratories Incの株主タイプ上位3種は、
First Eagle Investment Management, L.L.C.
The Vanguard Group, Inc.
Alice N. Schwartz Revocable Trust

Bio Rad Laboratories Inc(BIO)の株式を保有している機関の数はいくつですか?

2025Q4時点で、Bio Rad Laboratories Incの株式を保有している機関は1040社あり、保有株式の総市場価値は約20.58Mで、全体の101.60%を占めています。2025Q3と比較して、機関の持ち株は-1.58%増加しています。

Bio Rad Laboratories Incの最大の収益源は何ですか?

FY2025Q2において、--部門がBio Rad Laboratories Incにとって最大の収益を生み出しており、その金額は--で、全収益の--%を占めています。
KeyAI